Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Neoadjuvant Chemotherapy With and Without Immunotherapy to CA125 (Oregovomab) Followed by Hypofractionated Stereotactic Radiotherapy & Concurrent HIV Protease Inhibitor Nelfinavir in Locally Advanced Pancreatic Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01959672
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:32.291965+00:00
Published At
2019-11-15T00:00:00+00:00
Record Updated At
2023-10-10
Results Posted At
2019-11-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pancreatic Adenocarcinoma", "Resectable Pancreatic Carcinoma", "Stage I Pancreatic Cancer", "Stage IA Pancreatic Cancer", "Stage IB Pancreatic Cancer", "Stage II Pancreatic Cancer", "Stage IIA Pancreatic Cancer", "Stage IIB Pancreatic Cancer", "Stage III Pancreatic Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-10-10"
protocolSection.identificationModule.nctId
"NCT01959672"
protocolSection.identificationModule.officialTitle
"A Phase II Study of Neoadjuvant Chemotherapy With and Without Immunotherapy to CA125 (Oregovomab) Followed by Hypofractionated Stereotactic Radiotherapy \u0026 Concurrent HIV Protease Inhibitor Nelfinavir in Locally Advanced Pancreatic Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-11-15"

Study condition terms

  • Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Resectable Pancreatic Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage IA Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage IB Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIA Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIB Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Pancreatic Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.